Bloodworks
12
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
The Primary Purpose of This Study is to Determine if Biotin, Vitamin B7 is an Effective Way to Label Platelets in Survival and Recovery Studies.
Role: lead
Joint Health Study
Role: lead
Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets
Role: lead
Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets
Role: lead
A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease
Role: lead
Prospective Study of HIV Infection in Hemophiliacs
Role: lead
Cold Apheresis Platelets in PAS
Role: lead
Immunomodulation Following Transfusion
Role: collaborator
A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura
Role: lead
Comparison of Ideal vs. Actual Weight Base Factor Dosing
Role: lead
Assessment of Whole Blood Cold Stored Platelets
Role: lead
Retaining Donors and Increasing Donation Frequency
Role: lead
All 12 trials loaded